Società Briacell Therapeutics Corp Toronto S.E.
Azioni
CA10778Y1043
Biotecnologia
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 01/11/16 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 01/02/16 |
Chief Tech/Sci/R&D Officer | 53 | 01/05/21 | |
Chief Tech/Sci/R&D Officer | 62 | 16/02/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 10/05/16 |
Marc Lustig
BRD | Director/Board Member | 51 | 31/08/21 |
Rebecca Taub
BRD | Director/Board Member | 71 | 07/03/18 |
Director/Board Member | 66 | 18/03/19 | |
William Williams
CEO | Chief Executive Officer | 68 | 01/11/16 |
Jane Gross
BRD | Director/Board Member | 67 | 01/11/21 |
Chairman | 39 | 04/02/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 15 981 726 | 14 020 125 ( 87,73 %) | 0 | 87,73 % |
Coordinate società
BriaCell Therapeutics Corp.
Bellevue Centre 235 -15th Street
V7T 2X1, West Vancouver
+604 921 1810
http://www.briacell.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+8,29% | 114 Mrd | |
+10,21% | 104 Mrd | |
+0,15% | 22,28 Mrd | |
-11,90% | 22,41 Mrd | |
-5,52% | 19,07 Mrd | |
-37,36% | 18 Mrd | |
-5,17% | 17,89 Mrd | |
+7,70% | 14,28 Mrd | |
+37,65% | 12,55 Mrd |